Stayble Therapeutics presents at Financial Stockholm's investor meeting on September 25, 2023
Stayble Therapeutics AB ("Stayble" or "the Company") announces today that the Company will participate in the investor meeting "Investera som proffsen," organized by Financial Stockholm on September 25, 2023.On Monday, September 25, Stayble will be one of several companies presenting at Financial Stockholm's investor meeting at Scandic Anglais in Stockholm. At 17:50, Stayble's CEO, Andreas Gerward, will share insights about the Company's latest progress, future plans, and how Stayble is working to develop a treatment for degenerative disc disease and chronic disc herniation.To get more